Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

212022-06

NOTICE OF THE 2022 SECOND EXTRAORDINARY GENERAL MEETING
212022-06

(1) PROPOSED APPOINTMENT OF AN EXECUTIVE DIRECTOR；(2) PROPOSED APPOINTMENT OF A NON-EXECUTIVE DIRECTOR；（3）PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (4) NOTICE OF THE 2022 SECOND EXTRAORDINARY GENERAL MEETING
172022-06

(1) PROPOSED APPOINTMENT OF AN EXECUTIVE DIRECTOR；(2) PROPOSED APPOINTMENT OF A NON-EXECUTIVE DIRECTOR；(3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (4) CLOSURE OF REGISTER OF MEMBERS
152022-06

INSIDE INFORMATION-THE H SHARE FULL CIRCULATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE
062022-06

INSIDE INFORMATION - APPROVAL BY THE CSRC OF THE APPLICATION FOR H SHARE FULL CIRCULATION PROGRAMME OF THE COMPANY
062022-06

POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 6 JUNE 2022
062022-06

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
062022-06

ARTICLES OF ASSOCIATION
062022-06

(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 6 JUNE 2022; AND (2) APPOINTMENT OF NON-EXECUTIVE DIRECTOR
022022-06

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
272022-05

Environmental, Social and Governance Report 2021
192022-05

FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 6 JUNE 2022 OR AT ANY ADJOURNMENT THEREOF

9 10 11 12 13

The Enterprise OA